Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challenge
Abstract
Visceral leishmaniasis (VL) is an opportunistic infection of HIV-infected people in several endemic countries, and the management of this co-infection poses numerous challenges. We describe a patient with HIV infection and visceral leishmaniasis who failed to respond to miltefosine monotherapy and subsequently relapsed following two further different regimens of liposomal amphotericin B. He was then successfully treated with a combination of 30 mg/kg liposomal amphotericin B and 14 days of 100 mg/day oral miltefosine.Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S1201971214014532Language
enISSN
12019712ae974a485f413a2113503eed53cd6c53
10.1016/j.ijid.2014.02.015